Synthesis of [18F]fluoroetanidazole: A potential new tracer for imaging hypoxia

Nuclear Medicine and Biology

Volumn 24, Issue 8, 1997, Pages 755-760

  Tewson, T J ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Active esters; Fluorine 18; Fluoroethylamine; Hypoxia; Nitroimidazoles

Indexed keywords

FLUORINE 18; FLUOROETANIDAZOLE F 18; NITROIMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; ETANIDAZOLE; FLUORINE; FLUOROETANIDAZOLE; RADIOPHARMACEUTICAL AGENT; RADIOSENSITIZING AGENT;

ARTICLE; DRUG PURIFICATION; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOXIA; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; ANOXIA; CHEMISTRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; SCINTISCANNING; SYNTHESIS;

ANOXIA; ETANIDAZOLE; FLUORINE RADIOISOTOPES; ISOTOPE LABELING; RADIATION-SENSITIZING AGENTS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030608674     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00135-2     Document Type: Article

References (32)

1. Biskupiak J. E., Grierson J. R., Rasey J. S., Martin G. V. and Krohn K. A. (1991) Synthesis of an (indovinyl)misonidazole derivative for hypoxia imaging. J. Med. Chem. 34, 2165-2168.
2. Brown J. M., Yu N. Y., Brown D. M. and Lee W. W. (1981) SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use. Int. J. Radiat. Oncol. Biol. Phys. 7, 695-703.
3. Chapman J. D., Baer K. and Lee J. (1983) Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res. 43, 1523-1528.
4. 131I]iodoerythronitroimidazole. J. Drug Target. 4, 31-39.
5. Edwards D. I. (1993) Nitroimidazole drugs - action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 31, 9-20.
6. 14C-misonidazole to hypoxic cells in V79 spheroids. Br. J. Cancer 45, 694-699.
7. Gamper H. B., Reed M. W., Cox T., Virosco J. S., Adams A. D., Gall A. A., Scholler J. K. and Meyer R. B. (1993) Facile preparation of nuclease-resistant 3′ modified oligodeoxynucleotides. Nucl. Acids Res. 21, 145-150.
8. 14C-misonidazole. Br. J. Radiol. 56, 745-753.
9. Grierson J. R., Link J. M., Mathis C. A., Rasey J. S., and Krohn K. A. (1989) A radiosynthesis of fluorine-18 fluoromisonidazole. J. Nucl. Med. 30, 343-350.
10. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med. 27, 235-238.
11. 3H]misonidazole in cerebral ischemia. Stroke 18, 168-176.
12. 18F-labeled fluoronitroimidazoles: Potential in vivo markers of hypoxic tissue. Int. J. Rad. Appl. Instrum. A 37, 599-605.
13. 82Br]bromomisonidazole. Int. J. Nucl. Med. Biol. 10, 205-210.
14. Johnston T. P., McCaleb G. S., Opliger P. S. and Montgomery J. A. (1966) The synthesis of potential anticancer agents. XXXVI. N-nitrosoureas. II. Haloalkyl derivatives. J. Med. Chem. 9, 892-911.
15. Agrawal K. C., Bears K. B., Sehgal R. K., Brown J. N., Rist P. E. and Rupp W. D. (1979) Potential radiosensitizing agents: Dinitroimidazoles. J. Med. Chem. 22, 583-586.
16. Linder K. E., Chan Y. W., Cyr J. E., Malley M. F., Nowotnik D. P. and Nunn A. D. (1994) TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: Synthesis, characterization, and xanthine oxidase-catalyzed reduction. J. Med. Chem. 37, 9-17.
17. Love P., Cohen R. B. and Taft R. W. (1968) Polar substituent effects in gas-phase Lewis acid-base equilibria. I. Intrinsic basicity of amines. J. Am. Chem. Soc. 90, 2455-2462.
18. 3H]fluoromisonidazole in ischemic myocardium. J. Nucl. Med. 30, 194-201.
19. Martin G. V., Cerqueira M. D., Caldwell J. H., Rasey J. S., Embree L. and Krohn K. A. (1990) Fluoromisonidazole: A metabolic marker of myocyte hypoxia. Circ. Res. 67, 240-244.
20. Nunn A., Linder K. and Strauss H. W. (1995) Nitroimidazoles and imaging hypoxia. Eur. J. Nucl. Med. 22, 265-280.
21. Rasey J. S., Grunbaum Z., Magee S., Nelson N. J., Olive P. L., Durand R. E. and Krohn K. A. (1987) Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiat. Res. 111, 292-304.
22. 18F]fluoroetanidazole: A pretherapy study of 37 patients. Int. J. Radiat. Oncol. Biol. Phys. 36, 417-428.
23. Rasey J. S., Nelson N. J., Chin L., Evans M. L. and Grunbaum Z. (1990) Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. Radiat. Res. 122, 301-308.
24. 18F reaction. Radiochim. Acta 26, 21-25.
25. 18O]water using anion exchange resin. Int. J. Rad. Appl. Instrum. A 41, 531-533.
26. Soine T. O. and Buchdahl M. R. (1963) β-Bromoethylphthalimide. In: Organic Synthesis, vol. 4 (Edited by Rabjohn N.), pp. 106-108. John Wiley and Sons, New York.
27. 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 12, 1263-1267.
28. Von Sakellarios E. J. (1946) Phtalimidsynthesen mit Hilfe von p-Toluolsulfosäure-esteren. Helvetia Chim. Acta 29, 1675-1684.
29. 3H isotopmers of etanidazole (SR 2508). J. Label. Cmpds. Radiopharm. 28, 265-271.
30. Wiebe L. I., Jette D. C. and Chapman J. D. (1984) Electron-affinic compounds for labelling hypoxic cells: The synthesis and characterization of 1-[2-(2-iodophenoxy)-ethyl]-2-nitroimidazole. Nuklearmedicin 23, 63-67.
31. Yeh S. H., Liu R. S., Wu L. C., Yang D. J., Yen S. H., Chang C. W., Yu T. W., Chou K. L. and Chen K. Y. (1996) Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma. Eur. J. Nucl. Med. 23, 1378-1383.
32. Zheng L., Ma C., McCarthy T. J. and Welch M. J. (1994) Synthesis of 1-(2-nitro-1-imidazoyl)-3-(2-[F-18]-fluoromethyl-1-aziridinyl)-2-propanol [abstract]. J. Nucl. Med. 35, 73P.